{
}
Lloyds Bank's share price has risen 31% over the past year but faces challenges ahead, particularly with a Supreme Court case regarding car-loan mis-selling set to begin on April 1. The bank has set aside £1.15 billion for potential costs related to this issue, which could significantly impact its financial outlook. Meanwhile, Close Brothers Group has seen its share price drop 34% over the past year, with expectations of rising operating expenses and a forecast loss, raising concerns about its future performance.
Goldman Sachs has revised its year-end S&P 500 target down to 5,900 points, anticipating a 5% drop in the next three months due to weaker corporate profits, slower economic growth, and increased recession risks. The bank now projects U.S. GDP growth at 1.5% and expects earnings-per-share growth for the S&P 500 to slow to 3% in 2025 and 6% in 2026, significantly below analyst expectations. With a 35% chance of recession within a year, the S&P 500 could see a further decline of 25% from its February peak, potentially leading to a bottom around 4,600 points.
UBS Group AG has reduced its holdings in Renalytix PLC to below 5%, exempting the firm from reporting obligations. This shift may influence market dynamics and investor perceptions regarding Renalytix, a company focused on AI-enabled diagnostics for kidney disease. Year-to-date, Renalytix's stock has seen a price performance increase of 13.75%.
UBS AG has maintained a "Neutral" rating for Munich Reinsurance Company shares, setting a target price of 594 euros. Analyst Will Hardcastle favors life insurers over non-life insurers in the European sector, highlighting stocks like Prudential and AXA. Currently, Munich Re shares are trading at 583.60 EUR, reflecting a 1.02% decline, but still show a potential upside of 1.71% relative to the target price.
Three years ago, UBS shares were priced at CHF 18.15. An investment of CHF 10,000 would have resulted in 551,116 shares, now valued at CHF 15,398.18, reflecting a 53.98% increase, with the current share price at CHF 27.94 and a market capitalization of CHF 88.86 billion.
UBS has maintained a "Neutral" rating for Allianz shares, setting a target price of 320 euros, as analyst Will Hardcastle favors life insurers over non-life in Europe. Allianz shares fell 0.7% to EUR 352.80, with a 9.3% potential decline to the target price, despite a 19.2% rise since early 2025. The company is set to release its Q1 2025 balance sheet on May 15, 2025.
UBS Global Research has downgraded Scor to a “neutral” rating from “buy,” citing concerns over its dividend yield, which is seen as limiting stock price potential. Analysts highlight that Scor's current P/E ratio is below pre-COVID levels and unlikely to improve without a higher payout ratio or enhanced solvency. Additionally, Scor's debt leverage and capital generation forecasts pose further constraints, although there are positive signs in its P&C segment.
Goldman Sachs has revised its economic outlook, raising the U.S. recession probability to 35% and lowering GDP growth forecasts due to escalating tariff tensions. The bank anticipates deeper interest rate cuts from the Federal Reserve and ECB, with the eurozone facing a potential technical recession in 2025. New tariffs proposed by former President Trump could significantly impact both regions' economies, prompting further adjustments in growth projections.
UBS AG has maintained a "Neutral" rating on Allianz shares with a target price of €320, as analyst Will Hardcastle favors life insurers over non-life stocks. The Allianz share fell 0.7% to €352.80, indicating a potential downside of 9.3% relative to the target price, despite a 19.2% increase since the start of 2025. The company is set to release its Q1 2025 results on May 15, 2025.
UBS has reduced its price target for CTS Eventim from 120 to 116 euros while maintaining a "Buy" rating. Analyst Olivier Calvet anticipates strong growth in the ticket business and considers the company's live event targets to be conservative, despite lowering growth forecasts slightly.
Stock Market Updates
SubCategory
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Lloyds share price rises but faces challenges amid legal uncertainties
14:40 31.03.2025
goldman sachs cuts s and p 500 outlook amid economic concerns and tariffs
14:38 31.03.2025
ubs reduces stake in renalytix plc below five percent
14:30 31.03.2025
ubs maintains neutral rating for munich reinsurance company shares with target price
14:25 31.03.2025
ubs investment yields significant profit over three years
14:08 31.03.2025
ubs maintains neutral rating for allianz with target price of 320 euros
Euro
Swiss Re AG
Beazley plc
UBS AG
AXA SA
Allianz SE
Prudential plc
GBR
DEU
CHE
FRA
Will Hardcastle
Show more
14:08 31.03.2025
ubs downgrades scor to neutral citing dividend yield concerns
14:06 31.03.2025
goldman sachs warns of recession risks and deeper rate cuts ahead
14:06 31.03.2025
ubs maintains neutral rating on allianz shares with target price of 320 euros
13:49 31.03.2025
UBS lowers CTS Eventim price target but maintains buy rating
13:35 31.03.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Banking Regulations
Finance Mergers & Acquisitions
Global Financial Events
Retail and Consumer Goods
CEO Changes
Industry Mergers & Acquisitions
Central Bank Actions
Global Trade Developments
GDP Growth & Recession Forecasts
Financial Scams and Security
Market Analysis and Predictions
Inflation and Monetary Impact
Government Policies
Government Economic Policies
Workplace Trends
Startups & Entrepreneurship
Supply Chain Management
Countries:
Companies:
The Goldman Sachs Group, Inc.
JPMorgan Chase & Co.
Tesla, Inc.
Apple Inc.
Barclays PLC
Bank of America Corporation
Wells Fargo & Company
Citigroup Inc.
Deutsche Bank Money Market PP
Morgan Stanley
Huawei Technologies CO. Ltd.
Lloyds Banking Group plc
Credit Suisse Lux Digital Healt
Microsoft Corporation
UBS Group AG
Amazon.com, Inc.
Banco Santander, S.A.
Credit Suisse Strategic Income I
BNP Paribas SA
NVIDIA Corporation
Currencies:
United States Dollar
Euro
Chinese Yuan
British Pound Sterling
Swiss Franc
Japanese Yen
Indian Rupee
Russian Ruble
Australian Dollar
Canadian Dollar
United Arab Emirates Dirham
Indonesian Rupiah
Saudi Riyal
South Korean Won
Danish Krone
Offshore Chinese Yuan
Turkish Lira
Hong Kong Dollar
Mexican Peso
Malaysian Ringgit
People: